ROIV compared with IMVT: revenue, margins and what each company keeps, and the suppliers and customers both name

ROIVRoivant Sciences Ltd.

Mkt capRevenueRevenue

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

Compare

ROIVRoivant Sciences Ltd.

IMVTImmunovant, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

ROIVwithIMVT

×0.86co-movement · IMVT on ROIV · 500d

r 0.61scale to r 0.75

Shared co-movers5with ROIVwith IMVT

XNCRXencor Incr 0.41r 0.41

CLDXCelldex Therapeutics, Inc.r 0.39r 0.44

IDYAIDEAYA Biosciences, Inc.r 0.38r 0.49

DNLIDenali Therapeutics Inc.r 0.38r 0.45

KURAKura Oncology, Inc.r 0.38r 0.46

ROIV, solidIMVT, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

ROIVRoivant Sciences Ltd.

36.90· pre 37.02

Mkt cap$26.7BRevenue$1MQ1 FY26Revenue$8MFY25

IMVTImmunovant, Inc.

29.14· pre 29.17

Pre-marketSep 2 '83

Mkt cap$6.0BRevenue—Revenue—

Compare

Pre-marketSep 2 '83

ROIVRoivant Sciences Ltd.

IMVTImmunovant, Inc.

36.90pre 37.02

Price

29.14pre 29.17

$26.7B

Mkt cap

$6.0B

Q1 FY26$1M

Revenue

—

FY25$8M

Revenue

—

ROIV36.90vsIMVT29.14Pre-marketSep 2 '83